US-based drug maker Gilead Sciences Inc today signed licensing agreements for hepatitis C drugs with seven India-based firms, including Cipla,... ...http://www.business-standard.com/article/pti-stories/gilead-licenses-hepatitis-c-drugs-to-7-india-based-pharma-cos-114091500848_1.html
Stocks of Indian pharma companies seem to be in the pink ofhealth as investor-interest in them rises on the back of a weakening currency, the... ...http://www.business-standard.com/article/markets/weaker-currency-patent-expiration-boost-for-healthcare-cos-114091500656_1.html
10:30am Oil slips further The Sensex declined 193.64 points to 26867.40 and the Nifty dropped 55.40 points to 8050.10. Oil prices fell in Asia... ...http://www.moneycontrol.com/news/local-markets/nifty-breaks-8050-gail-hindalco-tata-steel-decline-2-3_1178962.html
10:20am Interview The Sensex fell 211.13 points to 26849.91 but Info Edge India rose 1.04 percent to Rs 882.30. Providers of online classifieds... ...http://www.moneycontrol.com/news/local-markets/nifty-breaks-8050-hdfc-bank-shines-cipla-extends-gains_1178962.html
Posted by Equitymaster Overall sentiment in the global markets remained weak as most of the developed markets ended the week in red. Less than a... ...http://www.equitymaster.com/tm/tm.asp?date=9/13/2014&title=Global-markets-end-on-a-weak-note
Miocon is pleased to introduce...